ANI Pharmaceuticals (ANIP)

[Rolling inflaton]

Also I am assuming current P/E multiples will stay unchanged. If management plans get realized the EBITDA run rate should basically double by the end of the year, and as first order approximation so should the stock price, leaving out corti.